Nuclear maspin detection in renal cell tumours: Possible diagnostic role and correlation with p53 status

Histopathology

Volumn 49, Issue 3, 2006, Pages 274-282

  Blandamura, S ^a,b   Giacomelli, L ^a   Leo, G ^a   Segato, P ^a   Ninfo, V ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Section of Anatomic Pathology   (Italy)

Author keywords

Maspin; p53; Renal cell tumours

Indexed keywords

MASPIN; PROTEIN P53;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY TUMOR; MAJOR CLINICAL STUDY; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS; SERPINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33747440370     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02504.x     Document Type: Article

References (20)

1. Tikoo SK, Reuter VE, Amin MB et al. Renal oncocytosis: a morphologic study of fourteen cases. Am. J. Surg. Pathol. 1999; 23; 1094-1101.
2. Delahunt B, Eble JN, McCredie MRE, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison with growth kinetics and patients survival in 26 cases. Hum. Pathol. 2001; 32; 590-595.
3. Jiang F, Richter J, Schraml P et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological types. Am. J. Pathol. 1998; 153; 1467-1473.
4. Gurova KV, Hill JE, Razorenova OV, Chumanov PM, Gudlov AV. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res. 2004; 64; 1951-1958.
5. Maass N, Hojo T, Zhang M, Sager R, Jonat W, Nagasaki K. Maspin - a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol. 2000; 39; 931-934.
6. Schneider SS, Schick C, Fish KE et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl Acad. Sci. USA 1995; 92; 3147-3151.
7. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 2000; 6; 196-199.
8. Bass R, Moreno Fernandez A-M, Ellis V. Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. 2002; 277; 46845-46848.
9. Son HJ, Sohn T-S, Song SY, Lee JH, Rhee JC. Maspin expression in human gastric adenocarcinoma. Pathol. Int. 2002; 52; 508-513.
10. Oshiro MM, Watts GS, Wozniak RJ et al. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 2003; 22; 3624-3634.
11. Yin S, Li X, Meng Y et al. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J. Biol. Chem. 2005; 280; 34985-34996.
12. Maass N, Hojo T, Ueding M et al. Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 2001; 7; 812-817.
13. Zhang W, Zhang M. Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. Int. J. Oncol. 2002; 20; 1145-1150.
14. Machtens S, Serth J, Bokemeyer C et al. Expression of p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int. J. Cancer 2001; 95; 337-342.
15. Zou Z, Anisowicz A, Hendrix MJC et al. Maspin, a serpin with tumor suppressing activity in human mammary epithelial cells. Science (Wash. DC) 1994; 263; 526-529.
16. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJC, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl Acad. Sci. USA 1996; 93; 11669-11674.
17. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res. 1997; 3; 1949-1958.
18. Sager R, Sheng S, Pemberton P, Hendrix MJC. Maspin. In Gunthert U, Birchmeier W eds. Current topics in microbiology and immunology. Attempts to understand metastasis formation I. Berlin: Springer-Verlag 1996; 213; 51-64.
19. Lonardo F, Li X, Siddiq F et al. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006; 51; 31-39.
20. Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology 2004; 63; 651-655.